Bei Wang, MPH

University of Chicago

Poster(s):

• (C-211) Immune-mediated adverse events in patients with high-risk melanoma receiving immune checkpoint inhibitors in adjuvant and first-line treatment settings: a real-world analysis
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET